Products
15201 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nvidia Constant Leverage with ISIN code: CH1290992705 | Nvidia | Constant Leverage | Long | ― | 189.096 | 0.08 | ― | ― | 1 | -2.44% | 53.85% | -1.23% | 5 Feb. 2024 | |
| Lonza Group Constant Leverage with ISIN code: CH1290992754 | Lonza Group | Constant Leverage | Long | ― | 531.574 | 4.32 | 0.080 | 4.4 | 1 | -1.82% | 7.73% | -6.90% | 5 Feb. 2024 | |
| Lonza Group Constant Leverage with ISIN code: CH1290992762 | Lonza Group | Constant Leverage | Long | ― | 531.574 | 1.13 | 0.030 | 1.16 | 1 | -2.59% | 9.71% | -11.72% | 5 Feb. 2024 | |
| Netflix Constant Leverage with ISIN code: CH1290992796 | Netflix | Constant Leverage | Long | ― | 93.481 | 11.09 | 0.090 | 11.18 | 1 | -1.51% | -8.20% | -48.47% | 5 Feb. 2024 | |
| S&P 500 Constant Leverage with ISIN code: CH1290992812 | S&P 500 | Constant Leverage | Short | ― | 6,908.78 | 0.867 | 0.001 | 0.868 | 1 | 0.23% | -13.47% | -16.55% | 16 Feb. 2024 | |
| Roche Constant Leverage with ISIN code: CH1290992838 | Roche | Constant Leverage | Long | ― | 327.054 | 11.42 | 0.130 | 11.55 | 1 | -1.13% | 27.17% | 44.19% | 16 Feb. 2024 | |
| Barrick Mining Constant Leverage with ISIN code: CH1290992853 | Barrick Mining | Constant Leverage | Long | ― | 45.665 | 22.28 | 0.360 | 22.64 | 1 | -0.80% | 38.64% | 145.92% | 16 Feb. 2024 | |
| Booking Constant Leverage with ISIN code: CH1290992879 | Booking | Constant Leverage | Long | ― | 5,435.908 | 3.11 | 0.200 | 3.31 | 1 | -5.47% | 2.98% | 61.98% | 16 Feb. 2024 | |
| RWE Constant Leverage with ISIN code: CH1290992887 | RWE | Constant Leverage | Long | ― | 44.695 | 3.4 | 0.080 | 3.48 | 1 | -2.30% | 12.96% | -1.45% | 16 Feb. 2024 | |
| Newmont Constant Leverage with ISIN code: CH1290992903 | Newmont | Constant Leverage | Long | ― | 105.264 | 88.45 | 0.530 | 88.98 | 1 | -0.58% | 22.37% | 96.91% | 16 Feb. 2024 | |
| Newmont Constant Leverage with ISIN code: CH1290992911 | Newmont | Constant Leverage | Long | ― | 105.264 | 19.8 | 0.120 | 19.92 | 1 | -0.65% | 35.15% | 164.71% | 16 Feb. 2024 | |
| Meta Platforms Constant Leverage with ISIN code: CH1290992929 | Meta Platforms | Constant Leverage | Short | ― | 664.841 | 0.26 | 0.020 | 0.28 | 1 | -3.70% | -13.33% | -33.33% | 16 Feb. 2024 | |
| Meta Platforms Constant Leverage with ISIN code: CH1290992937 | Meta Platforms | Constant Leverage | Long | ― | 664.841 | 4.35 | 0.070 | 4.42 | 1 | -2.47% | 5.07% | 25.36% | 16 Feb. 2024 | |
| Schneider Electric Constant Leverage with ISIN code: CH1290992945 | Schneider Electric | Constant Leverage | Long | ― | 235.4 | 0.91 | 0.010 | 0.92 | 1 | -2.15% | 9.64% | 13.75% | 16 Feb. 2024 | |
| PayPal Constant Leverage with ISIN code: CH1290992952 | PayPal | Constant Leverage | Long | ― | 59.411 | 0.012 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 16 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 328.458 | 0.27 | ― | ― | 1 | 0.00% | -57.81% | -73.79% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 328.458 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 23 Feb. 2024 | |
| DAX Constant Leverage with ISIN code: CH1290993125 | DAX | Constant Leverage | Short | ― | 24,324 | 0.161 | 0.001 | 0.162 | 1 | -0.62% | -14.36% | -32.07% | 11 Mar. 2024 | |
| DAX Constant Leverage with ISIN code: CH1290993133 | DAX | Constant Leverage | Short | ― | 24,324 | 1.762 | 0.001 | 1.763 | 1 | -0.06% | -7.75% | -17.89% | 11 Mar. 2024 | |
| CAC40 Constant Leverage with ISIN code: CH1290993141 | CAC40 | Constant Leverage | Short | ― | 8,100.11 | 4.893 | 0.006 | 4.899 | 1 | -0.99% | -2.47% | -8.80% | 11 Mar. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.